Sales of Krka group up 8.5% to record EUR 655m in H1

Otočec, 6 July - The Novo mesto-based pharmaceutical group Krka generated a record EUR 655m in sales in the first half of 2017, up 8.5% compared to the year before. Net profit meanwhile increased by 31% to EUR 91.7m, according to a report discussed on Thursday by Krka supervisors and presented at the annual general meeting.